Operating Expenses Summary of OncoSil Medical Limited

OncoSil Medical Limited's latest annual operating expenses in 2024 was 12.03 Million AUD , up 98.7% from previous year.
OncoSil Medical Limited's latest quarterly operating expenses in 2024 FY was 7.47 Million AUD , up 23.31% from previous quarter.
OncoSil Medical Limited reported a annual operating expenses of 6.05 Million AUD in annual operating expenses 2023, up 29.4% from previous year.
OncoSil Medical Limited reported a annual operating expenses of 4.68 Million AUD in annual operating expenses 2022, down -13.29% from previous year.
OncoSil Medical Limited reported a quarterly operating expenses of 3.39 Million AUD for 2024 Q2, down 0.0% from previous quarter.
OncoSil Medical Limited reported a quarterly operating expenses of 4.03 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of OncoSil Medical Limited (2024 - 2005)

Historical Annual Operating Expenses of OncoSil Medical Limited (2024 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2024	12.03 Million AUD	98.7%
2023	6.05 Million AUD	29.4%
2022	4.68 Million AUD	-13.29%
2021	5.39 Million AUD	-23.52%
2020	7.06 Million AUD	-42.94%
2019	12.37 Million AUD	-5.18%
2018	13.04 Million AUD	21.04%
2017	10.78 Million AUD	21.8%
2016	8.85 Million AUD	56.24%
2015	5.66 Million AUD	20.63%
2014	4.69 Million AUD	375.33%
2013	988.03 Thousand AUD	138.22%
2012	414.74 Thousand AUD	-17.73%
2011	504.11 Thousand AUD	-32.96%
2010	751.98 Thousand AUD	-57.24%
2009	1.75 Million AUD	-61.86%
2008	4.61 Million AUD	53.59%
2007	3 Million AUD	137.87%
2006	1.26 Million AUD	4906.1%
2005	25.21 Thousand AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 FY	7.47 Million AUD	23.31%
2024 Q2	3.39 Million AUD	0.0%
2024 Q4	4.03 Million AUD	0.0%
2023 FY	6.05 Million AUD	29.4%
2023 Q4	2.78 Million AUD	0.0%
2023 Q2	3.27 Million AUD	0.0%
2022 FY	4.68 Million AUD	-13.29%
2022 Q2	2.94 Million AUD	0.0%
2022 Q4	2.04 Million AUD	0.0%
2021 Q4	2.29 Million AUD	0.0%
2021 Q2	3.1 Million AUD	0.0%
2021 FY	5.39 Million AUD	-23.52%
2020 Q4	2.5 Million AUD	0.0%
2020 FY	7.06 Million AUD	-42.94%
2020 Q2	4.55 Million AUD	0.0%
2019 FY	12.37 Million AUD	-5.18%
2019 Q4	5.32 Million AUD	0.0%
2019 Q2	7.07 Million AUD	0.0%
2018 Q4	6.72 Million AUD	0.0%
2018 FY	13.04 Million AUD	21.04%
2018 Q2	6.4 Million AUD	0.0%
2017 Q2	4.14 Million AUD	0.0%
2017 FY	10.78 Million AUD	21.8%
2017 Q4	6.62 Million AUD	0.0%
2016 FY	8.85 Million AUD	56.24%
2016 Q2	4.36 Million AUD	0.0%
2016 Q4	4.51 Million AUD	0.0%
2015 FY	5.66 Million AUD	20.63%
2015 Q4	2.21 Million AUD	0.0%
2015 Q2	3.69 Million AUD	0.0%
2014 Q4	5.5 Million AUD	0.0%
2014 FY	4.69 Million AUD	375.33%
2014 Q2	1.92 Million AUD	0.0%
2013 Q4	758.75 Thousand AUD	2825.51%
2013 Q1	11.73 Thousand AUD	0.0%
2013 Q2	116.92 Thousand AUD	896.63%
2013 Q3	25.93 Thousand AUD	-77.82%
2013 FY	988.03 Thousand AUD	138.22%
2012 Q2	11.73 Thousand AUD	109.31%
2012 FY	414.74 Thousand AUD	-17.73%
2012 Q3	11.73 Thousand AUD	0.0%
2012 Q1	-126.02 Thousand AUD	0.0%
2012 Q4	11.73 Thousand AUD	0.0%
2011 Q1	187.99 Thousand AUD	0.0%
2011 Q3	-126.02 Thousand AUD	0.0%
2011 FY	504.11 Thousand AUD	-32.96%
2011 Q4	-126.02 Thousand AUD	0.0%
2011 Q2	-126.02 Thousand AUD	-167.04%
2010 Q3	187.99 Thousand AUD	0.0%
2010 Q2	187.99 Thousand AUD	1098.81%
2010 FY	751.98 Thousand AUD	-57.24%
2010 Q4	187.99 Thousand AUD	0.0%
2010 Q1	15.68 Thousand AUD	0.0%
2009 FY	1.75 Million AUD	-61.86%
2009 Q4	15.68 Thousand AUD	0.0%
2009 Q1	1.1 Million AUD	0.0%
2009 Q2	15.68 Thousand AUD	-98.58%
2009 Q3	15.68 Thousand AUD	0.0%
2008 Q2	1.1 Million AUD	47.46%
2008 Q1	749.2 Thousand AUD	0.0%
2008 FY	4.61 Million AUD	53.59%
2008 Q4	1.1 Million AUD	0.0%
2008 Q3	1.1 Million AUD	0.0%
2007 Q4	749.2 Thousand AUD	0.0%
2007 Q2	749.2 Thousand AUD	137.43%
2007 Q1	315.54 Thousand AUD	0.0%
2007 FY	3 Million AUD	137.87%
2007 Q3	749.2 Thousand AUD	0.0%
2006 FY	1.26 Million AUD	4906.1%
2006 Q4	315.54 Thousand AUD	0.0%
2006 Q2	315.54 Thousand AUD	5121.22%
2006 Q1	-6284.25 AUD	0.0%
2006 Q3	315.54 Thousand AUD	0.0%
2005 FY	25.21 Thousand AUD	0.0%
2005 Q3	-6284.25 AUD	0.0%
2005 Q2	-6284.25 AUD	0.0%
2005 Q4	-6284.25 AUD	0.0%

Peer Operating Expenses Comparison of OncoSil Medical Limited

Name	Operating Expenses	Operating Expenses Difference
4DMedical Limited	31.48 Million AUD	61.759%
Adherium Limited	267.7 Thousand AUD	-4397.462%
Aroa Biosurgery Limited	66.09 Million AUD	81.785%
Atomo Diagnostics Limited	1.6 Million AUD	-649.677%
Anteris Technologies Ltd	69.14 Million AUD	82.589%
Control Bionics Limited	9.82 Million AUD	-22.531%
CardieX Limited	16.64 Million AUD	27.684%
Compumedics Limited	26.88 Million AUD	55.209%
Cochlear Limited	1.17 Billion AUD	98.975%
CleanSpace Holdings Limited	11.35 Million AUD	-5.991%
Cyclopharm Limited	13.38 Million AUD	10.022%
EMVision Medical Devices Ltd	12.83 Million AUD	6.185%
Nova Eye Medical Limited	23.99 Million AUD	49.813%
HeraMED Limited	6.78 Million AUD	-77.501%
Imricor Medical Systems, Inc.	-1.11 Million AUD	1178.994%
ImpediMed Limited	28.04 Million AUD	57.063%
InhaleRx Limited	2.59 Million AUD	-364.763%
LBT Innovations Limited	1.1 Million AUD	-987.61%
Micro-X Limited	18.76 Million AUD	35.835%
Neurotech International Limited	8.75 Million AUD	-37.531%
PolyNovo Limited	34.92 Million AUD	65.524%
Respiri Limited	8.03 Million AUD	-49.845%
SomnoMed Limited	58.97 Million AUD	79.584%
Universal Biosensors, Inc.	20 Million AUD	39.801%
Uscom Limited	5.52 Million AUD	-118.111%
Visioneering Technologies, Inc.	9.63 Million AUD	-24.977%

Global Stocks Search

OncoSil Medical Limited (OSL.AX)

Operating Expenses Summary of OncoSil Medical Limited

Annual Operating Expenses Chart of OncoSil Medical Limited (2024 - 2005)

Historical Annual Operating Expenses of OncoSil Medical Limited (2024 - 2005)

Peer Operating Expenses Comparison of OncoSil Medical Limited